Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.22.1
Equity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 31, 2020
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Equity (Details) [Line Items]        
Unrecognized compensation expense   $ 4.4    
Weighted average term   3 years 1 month 6 days    
Compensation expense related to stock options   $ 0.4 $ 0.4  
Capital on Demand Sales Agreement [Member]        
Equity (Details) [Line Items]        
Aggregate value of common stock $ 200.0      
Sale of common stock, shares (in Shares)     1,700 6,700
Gross proceeds     $ 14.8 $ 59.1
Net proceeds     $ 14.4 $ 57.0
Equity Option [Member]        
Equity (Details) [Line Items]        
Stock options granted (in Shares)   5    
Stock option term   10 years    
Vesting period of stock option   4 years    
Aggregate fair value   $ 22.0    
Stock option, description   (1) discount rate range from 1.52% to 1.96% (2) expected life of 6 years, (3) expected volatility range from 78.8% to 80.0%, and (4) zero expected dividends.    
Equity Option [Member] | Minimum [Member]        
Equity (Details) [Line Items]        
Exercise price (in Dollars per share)   $ 5.2    
Equity Option [Member] | Maximum [Member]        
Equity (Details) [Line Items]        
Exercise price (in Dollars per share)   $ 5.93